Ujwala Mahatme

Insider Reports History

Entity
Individual
Location
One Broadway, 14 Th Floor, Cambridge, MA
Signature
/s/ Ankur Dhingra, as Attorney-in-Fact for Ujwala Mahatme
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ujwala Mahatme:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Summit Therapeutics Inc. Director Stock Option (right to buy) 87.6K $116K $1.32 Jan 2, 2024 Direct

Insider Reports Filed by Ujwala Mahatme

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SMMT Summit Therapeutics Inc. Jan 2, 2024 2 $69.4K 4 Jan 4, 2024 Director
SMMT Summit Therapeutics Inc. Jan 3, 2023 2 $67.6K 4 Jan 5, 2023 Director
SMMT Summit Therapeutics Inc. Jan 3, 2022 2 $54.1K 4 Jan 5, 2022 Director